Stocks
F-D-A spells bad news for biotech
The FDA vaccine division is in for big changes under RFK, and biotech stocks are in the crosshairs.
Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.
By subscribing, you accept our Terms & Privacy Policy.